Last updated 17 days ago

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease.

300 patients around the world
Available in Argentina, United States, Spain
Hoffmann-La Roche
9Research sites
300Patients around the world
This study is for people with
Rare diseases
Huntington's chorea
Requirements for the patient
To 50 Years
All Gender
Medical requirements
Sites
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Recruiting
Viamonte 2278, CABA, Buenos Aires
INEBA
Recruiting
Guardia Vieja 4435, C1192AAW CABA, Argentina
Hospital Universitario de Badajoz - HUB
Recruiting
Av. de Elvas, s/n, 06080 Badajoz
Hospital Santa Creu i Sant Pau
Recruiting
C/ de Sant Quintí, 77, 08041 Barcelona, Spain
Hospital Universitario de Burgos
Recruiting
Av. Islas Baleares, 3, 09006 Burgos
Hospital Universitario Ramón y Cajal
Recruiting
Madrid, 28034
Hospital Universitario Virgen de la Macarena
Recruiting
Avenida Dr. Fedriani, 3, 41009, Sevilla
Hospital Universitari i Politecnic La Fe
Recruiting
46026 Valencia, Spain
Hospital Universitario de Cruces
Recruiting
Cruces Plaza, s/n, 48903 Barakaldo, Bizkaia
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy